News

Researchers have tested an algorithm on 700,000 patient records in east London, to find out if the data routinely collected by GPs can reveal cases of Familial Hypercholesterolemia - a leading cause of heart attack in young people. The study was published in the journal Heart.

A new study identifies the presence of the elemental metals iron and copper within plaques taken from the brains of people with Alzheimer’s disease (AD).

A study suggests that weakened electrical signals in the brain may be an early warning sign of age-related neurodegenerative diseases such as Alzheimer’s disease.

A multidisciplinary team led by researchers from the Spanish Research Council (CSIC) identified the genomic cellular map associated with hippocampal sclerosis, a major histopathological condition of temporal lobe epilepsy.

Women who will develop potentially life-threatening disorders during pregnancy can be identified early when hormone levels in the placenta are tested, a new study has shown.

Researchers have shown that a non-toxic complex of manganese makes it possible to conveniently label peptides right at the last minute of their synthesis. This means the mechanism of action of these labeled peptides can be investigated efficiently.

The new method, RApid DIgital Crispr Approach (RADICA), is a molecular testing methodology that allows absolute quantification of viral nucleic acids in 40-60 minutes. It is four times faster and significantly less expensive than conventional polymerase chain reaction methods as it does not require costly equipment for precise temperature control and cycling.

A new study of over 3000 people has shown for the first time that a single biomarker can accurately indicate the presence of underlying neurodegeneration in people with cognitive issues.

A first encounter with the dengue virus typically causes very mild symptoms; however, a subsequent infection is a different story. For a small proportion of people who are re-infected, the virus can cause severe symptomatic disease, and it appears this could be due to a particular type of antibody.

A biomarker in the blood of patients with bowel cancer may provide valuable insight into the risk of cancer relapse after surgery and the effectiveness of chemotherapy.